NasdaqGS - Nasdaq Real Time Price USD

Acadia Healthcare Company, Inc. (ACHC)

Compare
76.40 -1.04 (-1.34%)
At close: September 20 at 4:00 PM EDT
76.40 0.00 (0.00%)
After hours: September 20 at 4:39 PM EDT
Loading Chart for ACHC
DELL
  • Previous Close 77.44
  • Open 77.20
  • Bid 76.30 x 100
  • Ask 76.47 x 300
  • Day's Range 76.31 - 77.62
  • 52 Week Range 62.04 - 87.77
  • Volume 903,480
  • Avg. Volume 910,303
  • Market Cap (intraday) 7.095B
  • Beta (5Y Monthly) 1.30
  • PE Ratio (TTM) --
  • EPS (TTM) -0.08
  • Earnings Date Oct 31, 2024 - Nov 4, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 89.33

Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.

www.acadiahealthcare.com

23,500

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ACHC

View More

Performance Overview: ACHC

Trailing total returns as of 9/20/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ACHC
1.75%
S&P 500
19.55%

1-Year Return

ACHC
9.44%
S&P 500
28.32%

3-Year Return

ACHC
24.80%
S&P 500
28.64%

5-Year Return

ACHC
136.46%
S&P 500
89.66%

Compare To: ACHC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ACHC

View More

Valuation Measures

Annual
As of 9/20/2024
  • Market Cap

    7.10B

  • Enterprise Value

    8.99B

  • Trailing P/E

    --

  • Forward P/E

    19.61

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.28

  • Price/Book (mrq)

    2.40

  • Enterprise Value/Revenue

    2.94

  • Enterprise Value/EBITDA

    38.00

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -0.17%

  • Return on Assets (ttm)

    6.13%

  • Return on Equity (ttm)

    0.13%

  • Revenue (ttm)

    3.06B

  • Net Income Avi to Common (ttm)

    -5.12M

  • Diluted EPS (ttm)

    -0.08

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    77.17M

  • Total Debt/Equity (mrq)

    64.41%

  • Levered Free Cash Flow (ttm)

    -143.48M

Research Analysis: ACHC

View More

Company Insights: ACHC

Research Reports: ACHC

View More

People Also Watch